Next-generation sequencing - Insights
Learn more about the advantages offered by Mayo Clinic Laboratories’ next-generation sequencing panel for plasma cell neoplasms.
Children's Oncology Group - Insights
Learn how our team’s commitment and large testing menu helps in meeting the specific needs of Children’s Oncology Group patients.
Non-Colorectal GI Tumor Testing - Mayo Clinic Laboratories
Mayo Clinic Laboratories offers additional testing for GIST tumors and several other types of non-colorectal GI tumors.
Serotonin release assay - Insights
Find out more about our serotonin release assay, the gold standard diagnostic test for detecting heparin-induced thrombocytopenia antibodies.
Comprehensive neuromuscular panel - Insights
Find out how the emergence of advanced molecular testing technologies has enhanced the detection of inherited neuromuscular disorders.
Learn how our muscular dystrophy genetic testing can help patients access variant-specific therapies and determine eligibility for clinical trials.
Sleep Disorder Testing - Mayo Clinic Laboratories
Determining orexin-A/ hypocretin-1 levels through CSF testing provides a sensitive and specific result to guide appropriate treatment for patients.
Hereditary hearing loss - Insights
Learn how our hereditary hearing loss test can help avoid unnecessary workups and appointments and reduce anxiety for patients and their families.
Amyloidosis Testing - Mayo Clinic Laboratories
Mayo Clinic’s amyloid protein identification methodology is considered the gold standard because of the high sensitivity and accuracy with which it types amyloid proteins in paraffin-embedded specimens.
Mayo Clinic Laboratory and pathology research roundup: September 12 - Insights
This week's research roundup feature: Activated mast cells in periprosthetic joint infection-associated tissue.